Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

4.7K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Bone Remodeling01:40

Bone Remodeling

38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Bone Disorders01:29

Bone Disorders

3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

462
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors predicting cure at one year after administration of radioactive iodine to patients with Graves' disease.

Hellenic journal of nuclear medicine·2025
Same author

Epidemiology, presentation and outcomes in pituitary apoplexy: a population-based study in Malta.

Endocrine oncology (Bristol, England)·2025
Same author

Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective.

Endocrine oncology (Bristol, England)·2025
Same author

Paediatrics and genetics.

Clinical and experimental dermatology·2025
Same author

Not all ketosis is type 1 - remember Flatbush.

British journal of hospital medicine (London, England : 2005)·2024
Same author

High Population Frequency of <i>GNRHR</i> p.Q106R in Malta: An Evaluation of Fertility and Hormone Profiles in Heterozygotes.

Journal of the Endocrine Society·2024
Same journal

Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Prolonged Undiagnosed Prodromal Symptoms.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Human Factors and Deterioration: What Success Factors Facilitate Escalation of Care and How Can These Be Applied More Reliably?

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Comparative Evaluation of Functional Outcomes and Postoperative Complications After Minimally Invasive Fixation for Acromioclavicular Joint Injuries.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

A Systematic Review of Functional MRI Studies on Seasonal Modulation of Brain Functional Connectivity.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

More Than Myocarditis? Cardiac Involvement in Phaeochromocytoma-A Case Report.

British journal of hospital medicine (London, England : 2005)·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

A Mini-Invasive Internal Fixation Technique for Studying Immobilization-Induced Knee Flexion Contracture in Rats
05:34

A Mini-Invasive Internal Fixation Technique for Studying Immobilization-Induced Knee Flexion Contracture in Rats

Published on: May 20, 2019

8.1K

Immobilisation hypercalcaemia.

Simon Mifsud1, Emma L Mifsud2, Stefanie M Agius2

  • 1Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.

British Journal of Hospital Medicine (London, England : 2005)
|July 5, 2022
PubMed
Summary
This summary is machine-generated.

Immobility can cause hypercalcaemia (high blood calcium), a condition independent of parathyroid hormone. Early mobilization and specific treatments are key for managing this rare metabolic abnormality.

Keywords:
BisphosphonatesDenosumabHypercalcaemiaImmobilisationRehabilitation

More Related Videos

In Vivo Calcium Imaging in C. elegans Body Wall Muscles
08:03

In Vivo Calcium Imaging in C. elegans Body Wall Muscles

Published on: October 20, 2019

7.8K
Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
07:49

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes

Published on: September 20, 2019

5.8K

Related Experiment Videos

Last Updated: Sep 5, 2025

A Mini-Invasive Internal Fixation Technique for Studying Immobilization-Induced Knee Flexion Contracture in Rats
05:34

A Mini-Invasive Internal Fixation Technique for Studying Immobilization-Induced Knee Flexion Contracture in Rats

Published on: May 20, 2019

8.1K
In Vivo Calcium Imaging in C. elegans Body Wall Muscles
08:03

In Vivo Calcium Imaging in C. elegans Body Wall Muscles

Published on: October 20, 2019

7.8K
Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
07:49

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes

Published on: September 20, 2019

5.8K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Bone Biology

Background:

  • Hypercalcaemia is a common metabolic abnormality with a broad differential diagnosis.
  • Immobility is an infrequent yet significant cause of hypercalcaemia.
  • Immobilisation hypercalcaemia is distinct from other causes, being parathyroid hormone-independent.

Purpose of the Study:

  • To highlight immobilisation hypercalcaemia as a diagnosis of exclusion.
  • To inform physicians about this condition to prevent unnecessary investigations.
  • To outline current and potential management strategies.

Main Methods:

  • Literature review and synthesis of existing knowledge on immobilisation hypercalcaemia.
  • Analysis of biochemical markers associated with the condition (e.g., vitamin D levels, bone resorption markers).
  • Review of treatment modalities including mobilization, pharmacotherapy, and potential novel agents.

Main Results:

  • Immobilisation hypercalcaemia is characterized by low vitamin D levels (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D).
  • Elevated bone resorption markers and low bone-specific alkaline phosphatase indicate a bone remodelling imbalance favoring osteoclasts.
  • Management includes early mobilization, rehabilitation, and pharmacotherapies like saline, calcitonin, and bisphosphonates.

Conclusions:

  • Physicians must consider immobilisation hypercalcaemia in the differential diagnosis of hypercalcaemia, especially after excluding other causes.
  • Early mobilization and rehabilitation are crucial for managing immobilisation hypercalcaemia.
  • Pharmacological interventions and potentially denosumab in renal insufficiency offer therapeutic options.